Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.

Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.

Although growth hormone (GH) replacement therapy is increasingly utilized in the management of adult hypopituitary patients, optimum dosing schedules are poorly defined. The use of weight-based or surface area-based dosing may result in overtreatment, and individual variation in susceptibility on th...

Повний опис

Бібліографічні деталі
Автори:	Drake, WM, Coyte, D, Camacho-Hübner, C, Jivanji, N, Kaltsas, G, Wood, D, Trainer, P, Grossman, AB, Besser, G, Monson, J
Формат:	Journal article
Мова:	English
Опубліковано:	1998

Схожі ресурси

Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
за авторством: Florakis, D, та інші
Опубліковано: (2000)

Comments on 'Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study' by Florakis et al (2000) - Reply
за авторством: Monson, J, та інші
Опубліковано: (2001)

Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.
за авторством: Frajese, G, та інші
Опубліковано: (2001)

Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
за авторством: Chung, T, та інші
Опубліковано: (2008)

Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
за авторством: Agha, A, та інші
Опубліковано: (2007)

Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years.
за авторством: le Roux, C, та інші
Опубліковано: (2002)

Role of fasting plasma glucose, glycated haemoglobin and homeostatic model assessment in the detection of glucose intolerance in adult hypopituitary patients during growth hormone replacement therapy.
за авторством: Colson, A, та інші
Опубліковано: (2008)

Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
за авторством: Chung, T, та інші
Опубліковано: (2005)

Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.
за авторством: Kaltsas, G, та інші
Опубліковано: (2001)

Insulin-like growth factor-I and- II in combination inhibit the release of growth hormone-releasing hormone from the rat hypothalamus in vitro.
за авторством: Korbonits, M, та інші
Опубліковано: (1996)

The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults.
за авторством: Sverrisdóttir, Y, та інші
Опубліковано: (2003)

Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration.
за авторством: Jenkins, P, та інші
Опубліковано: (2000)

Growth hormone deficiency and replacement in patients with treated Cushing's Disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density.
за авторством: Colson, A, та інші
Опубліковано: (2006)

The modulation of platelet function by growth hormone in growth hormone deficient Hypopituitary patients
за авторством: Irene K Oglesby, та інші
Опубліковано: (2023-09-01)

The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
за авторством: Korbonits, M, та інші
Опубліковано: (1999)

Hexarelin as a test of pituitary reserve in patients with pituitary disease.
за авторством: Korbonits, M, та інші
Опубліковано: (1999)

Pyridostigmine partially reverses dexamethasone-induced inhibition of the growth hormone response to growth hormone-releasing hormone.
за авторством: Trainer, P, та інші
Опубліковано: (1992)

Authors' response: The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women
за авторством: Kaltsas, G, та інші
Опубліковано: (2003)

The prevalence and characteristic features of cyclicity and variability in Cushing's disease.
за авторством: Alexandraki, K, та інші
Опубліковано: (2009)

How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
за авторством: Kaltsas, G, та інші
Опубліковано: (2000)

Classic cardiovascular risk factors improve in very elderly hypopituitary patients treated on standard hormone replacement in long term follow- up
за авторством: Isabella Naves Rosa, та інші
Опубліковано: (2021-03-01)

CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing's syndrome.
за авторством: Sohaib, SA, та інші
Опубліковано: (1999)

Complications of inferior petrosel sinus sampling.
за авторством: Kaltsas, G, та інші
Опубліковано: (2000)

Circulating Levels of Irisin in Hypopituitary and Normal Subjects.
за авторством: Lara Pena-Bello, та інші
Опубліковано: (2016-01-01)

Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome.
за авторством: Korbonits, M, та інші
Опубліковано: (1995)

Prevalence and risk factors of the metabolic syndrome in young adults with childhood-onset hypopituitary growth hormone deficiency
за авторством: Han Hyuk Lim, та інші
Опубліковано: (2010-10-01)

Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy.
за авторством: Swords, F, та інші
Опубліковано: (2009)

The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors.
за авторством: Kaltsas, G, та інші
Опубліковано: (1998)

Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
за авторством: Isidori, A, та інші
Опубліковано: (2003)

Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients
за авторством: Hugo L. Fideleff, та інші
Опубліковано: (2016-02-01)

Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
за авторством: Newell-Price, J, та інші
Опубліковано: (2002)

NITRIC-OXIDE AS A NOVEL REGULATOR OF NEUROENDOCRINE FUNCTION - CONTROL OF CORTICOTROPIN-RELEASING HORMONE-41 RELEASE FROM THE RAT HYPOTHALAMUS INVITRO
за авторством: Costa, A, та інші
Опубліковано: (1992)

Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
за авторством: Korbonits, M, та інші
Опубліковано: (1998)

A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.
за авторством: Miraki-Moud, F, та інші
Опубліковано: (2005)

A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome.
за авторством: Kaltsas, G, та інші
Опубліковано: (1999)

Initial response of young people with thyrotoxicosis to block and replace or dose titration thionamide
за авторством: Claire L Wood, та інші
Опубліковано: (2023-01-01)

Clinical, radiological and pathological features of patients with Rathke's cleft cysts: tumors that may recur.
за авторством: Mukherjee, J, та інші
Опубліковано: (1997)

BENZODIAZEPINES ATTENUATE THE SERUM CORTISOL RESPONSE TO CORTICOTROPIN-RELEASING HORMONE (CRH) IN HEALTHY-VOLUNTEERS
за авторством: Trainer, P, та інші
Опубліковано: (1992)

No clear evidence for an association between GH replacement and relapse of intracranial germ cell tumours: single centre and KIMS experience.
за авторством: Chung, T, та інші
Опубліковано: (2010)

Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro.
за авторством: Costa, A, та інші
Опубліковано: (1993)